Pearl Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 25 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 35.00 Cr
as on 25-12-2024
- Satisfied Charges ₹ 18.10 Cr
as on 25-12-2024
- Revenue 40.51%
(FY 2022)
- Profit 53.04%
(FY 2022)
- Ebitda 53.88%
(FY 2022)
- Net Worth -45.42%
(FY 2022)
- Total Assets -0.92%
(FY 2022)
About Pearl Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹35.00 Cr. The company has closed loans amounting to ₹18.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Manickam, Manthan Kothari, Muthu, and One other member serve as directors at the Company.
- CIN/LLPIN
U85120TN1999PTC042837
- Company No.
042837
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 1999
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pearl Medicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Manickam  | Director | 22-Jun-2024 | Current |
| Manthan Kothari | Director | 22-Apr-2024 | Current |
| Muthu | Director | 01-Nov-2021 | Current |
| Varun Mehta | Director | 16-Aug-2024 | Current |
Financial Performance of Pearl Medicals.
Pearl Medicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.51% increase. The company also saw a substantial improvement in profitability, with a 53.04% increase in profit. The company's net worth observed a substantial decline by a decrease of 45.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pearl Medicals?
In 2020, Pearl Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rau And Co Pharma Private LimitedActive 8 years 10 monthsSrinivasa Manickam and Varun Mehta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 21 Oct 2019 | ₹35.00 Cr | Open |
Others Creation Date: 01 Nov 2017 | ₹5.50 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 11 Jul 2017 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Pearl Medicals?
Pearl Medicals has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pearl Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pearl Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
